Once-weekly insulin icodec as novel treatment for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials
Authors:
- 28 October 2023
- journal article
- review article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 205, 110984
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The barriers against initiating insulin therapy among patients with diabetes living in Yazd, IranDiabetes, Metabolic Syndrome and Obesity, 2019
- Glycaemic Control for People with Type 2 Diabetes Mellitus in Bangladesh - An urgent need for optimization of management planScientific Reports, 2019
- Time to Insulin Initiation in Type 2 Diabetes Patients in 2010/2011 and 2016/2017 in GermanyJournal of Diabetes Science and Technology, 2019
- Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of DiabetesDiabetologia, 2016
- Type 2 diabetes mellitusNature Reviews Disease Primers, 2015
- Patient perspectives on once‐weekly medications for diabetesDiabetes, Obesity and Metabolism, 2010
- Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivityIndian Journal of Clinical Biochemistry, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Adjusting for publication bias in the presence of heterogeneityStatistics in Medicine, 2003
- Publication bias in meta-analysis its causes and consequencesJournal of Clinical Epidemiology, 2000